Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Nature Reviews. Clinical Oncology|July 5, 2017
Precision medicine based on epigenomics: the paradigm of carcinoma of unknown primarySebastián Moran, Anna Martinez-Cardús, Stergios Boussios, et al.
Annals of Translational Medicine|October 22, 2015
Epigenetic mechanisms involved in melanoma pathogenesis and chemoresistanceAnna Martinez-Cardús, Miguel Vizoso, Sebastian Moran, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|December 4, 2025
Same mutation, different fates: The Yin-Yang of BRAF-driven therapeutic responses in melanoma and colorectal cancerCarme Solé-Blanch, Sofia España, Alba de la Puente-Noel, et al.
Epigenetics|April 16, 2014
Validation of DNA methylation profiling in formalin-fixed paraffin-embedded samples using the Infinium HumanMethylation450 MicroarraySebastián Moran, Miguel Vizoso, Anna Martinez-Cardús, et al.
Cancer Treatment Reviews|July 1, 2022
Biological and clinical perspectives of the actionable gene fusions and amplifications involving tyrosine kinase receptors in lung cancerMaria Saigí, Enric Carcereny, Teresa Morán, et al.
Frontiers in Oncology|March 7, 2024
Targeted therapy or immunotherapy in BRAF-mutated metastatic melanoma: a Spanish center's decade of experienceChen Sun, Sofia España, Nina Richarz, et al.
Molecular Cancer Therapeutics|April 18, 2009
A proteomic approach links decreased pyruvate kinase M2 expression to oxaliplatin resistance in patients with colorectal cancer and in human cell linesEva Martinez-Balibrea, Carmen Plasencia, Alba Ginés, et al.
Molecular Cancer Therapeutics|January 14, 2009
Pharmacogenomic approach for the identification of novel determinants of acquired resistance to oxaliplatin in colorectal cancerAnna Martinez-Cardús, Eva Martinez-Balibrea, Eva Bandrés, et al.
Journal of Clinical Medicine|February 15, 2022
Prognostic Impact of CD36 Immunohistochemical Expression in Patients with Muscle-Invasive Bladder Cancer Treated with Cystectomy and Adjuvant ChemotherapyJuan Carlos Pardo, Tamara Sanhueza, Vicenç Ruiz de Porras, et al.
Journal of the National Cancer Institute|November 26, 2013
Epigenetic inactivation of the BRCA1 interactor SRBC and resistance to oxaliplatin in colorectal cancerCatia Moutinho, Anna Martinez-Cardús, Cristina Santos, et al.
Pageof 2